OMICS and brain tumour biomarkers

V. Petřík,A. Loosemore,F. Howe,B. Bell,M. Papadopoulos
DOI: https://doi.org/10.1080/02688690600999620
2006-01-01
British Journal of Neurosurgery
Abstract:Currently, brain tumours are diagnosed by surgical biopsy and light microscopic examination of tissue, with immunohistochemistry in difficult cases. We review research in the field of brain tumour diagnosis and discuss several new approaches. In future, tumour type, optimal treatment, and prognosis could be obtained by studying the gene (genomics), protein (proteomics) or metabolite (metabolomics) content of tumour cells. These techniques generate complex data, analysed using techniques such as pattern recognition software to identify biomarker signatures of different tumours. Compared with individual biomarkers, biomarker signatures appear to increase diagnostic accuracy and may produce an improved brain tumour classification system.
What problem does this paper attempt to address?